Medical network - on May 11, recently, the guangdong province of the latest drug deal, 158 medical institutions (including the grassroots health institutions) complain some enterprise altogether 512 product gauge drugs are not enough supply in time, lead to clinical drug supply is insufficient. 

 

The guangdong drug trade center said the second infraction will be disqualified from the market in guangdong for two years. 

 

There is no break for 512 quality rules 

 

According to the complaints of provincial hospitals, the guangdong pharmaceutical trading center investigated and analyzed the purchasing of medical institutions in the province. The results showed that the agreement involved 1,004 contracts and 512 articles. 

 

The official 512 rules have not been fully broken and have been delivered to the present day. Except the children acetaminophen alkyl amine particles, ligustrazine phosphate pieces and 2 varieties of provincial distribution rate below 10%, most product gauge province distribution rate is higher than 70%, the province outages did not happen. 

 

For the variety of the public are not in accordance with the contract delivery, guangdong province development planning commission's report said basically has the following several aspects: one is production enterprises failed to timely pay attention to drug distribution; Secondly, the distribution enterprises are not willing to distribute the medical supplies due to the lack of procurement of some medical institutions; Third, the pharmaceutical GMP certificate, the expiration of GSP certificate and the production line transformation will not be produced in the short term. Fourth, the monopoly of raw materials and the sharp increase in prices caused the shortage of raw materials for pharmaceutical production, affecting the production of medicines on demand. 

 

First, the two criminal enterprises were banned from guangdong 

 

Recently, guangdong pharmaceutical trading center according to the interim measures for the supervision and administration of medical institutions and drug trade in guangdong province (hereinafter referred to as the measures for supervision and management) regulations, for the latest drug deal, be part of the complaints of medical institutions in accordance with the contract or not timely supply of adequate supply of product gauge and corresponding information such as the production and distribution enterprise to carry on the public. 

 

The official explanation is that the period of public notice is the time of rectification, which is not dealt with during this period. Exceed the time limit still not corrected relevant product gauge will be made by province who planning commission jointly with relevant departments according to the supervision and management measures for article 12, paragraph 6 of a violation to cancel the goods regulations within two years in this province entry qualifications, secondary violations will be listed in the guangdong pharmaceutical production enterprises dishonest trade list, cancel all the enterprise product entry qualification in guangdong for two years. The purpose is to supervise the parties to ensure the supply of medicines. 

 

In order to protect the legitimate rights and interests of all parties concerned, the establishment of the list system and market clearing mechanism in guangdong in 2014 was established. It is important to monitor and manage the contents of non-performance or not timely delivery. 

 

Since the establishment of the relevant mechanism, guangdong has conducted routine supervision of 5 batches, and has achieved remarkable results. According to statistics, the first 4 94.55% of the products in a batch by public variety rules to complete the rectification within prescribed time limit, no improvement of varieties has been included in the credit transaction list, and have been disqualified from trading in guangdong for two years.